Neuropatia diabética: fisiopatologia, clínica e eletroneuromiografia

Authors

  • Rafael José Soares Dias Clínica de Eletroneurofisiátria Armando Carneiro
  • Armando Pereira Carneiro Clínica de Eletroneurofisiátria Armando Carneiro

DOI:

https://doi.org/10.11606/issn.2317-0190.v7i1a102254

Keywords:

Diabetic Neuropathies, Electrophysiology, Physiophatology

Abstract

The neuropathy affects most of the diabetics of long term. Its best understanding is of up importance in the development of a correct clinical ratiocination. The main physiopathological way, clinical presentation and electrophysiological feature are revised by means of research in MedLine and some personal data are presented. Knowledge of patophysiology, clinical, and electrophysiology is essential for a critical and rational of that heterogeneous and complex pathology.

Downloads

Download data is not yet available.

References

Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular diasease, infection neuropathy, and ulceration in diabetes. Diabetes Care. 1998;21:42-48.

Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-1402.

Cabezas-Carrero J. The prevalence of clinical diabetic polineuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998;41:1263-1269.

Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med. 1998;91:733-737.

Grenne DA, Sima AAF, Stevens MJ, Feldman EL, Lattimers A. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 1992;15:1902-1925.

Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and management of diabetic peripheral neuropathy. Diab Med. 1998;15:508-514.

Thomas PK, Tomlinson DR. Diabetic and hipoglicemic neuropathy. In: Dick PJ. Peripheral neuropathy. Philadelphia: Saunders; 1993. p. 1219-1250.

Ross MA. Neuropathies associated with diabetes. Med Clin North Am. 1993;77:111-124.

Dyck PJ, Kratz KM, Karnes MS. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy study. Neurology. 1993;43:817-824.

American Diabetes Associations. American Academy Of Neurology. Report and recomendations of the Santo Antonio conference on diabetic neuropathy. Diabetes Care. 1988;11:592-596.

Sangiorgio L, Iemmolo R, Le Moli R. Diabetic neuropathy: prevalence, concordance between clinical and electrophysiological testing and impact of risk factors. Panminerva Med. 1997;39:1-5.

Partanen J, Niskanen L, Lehtinen J. Natural history of peripheral neuropathy in patients with non-insulindependent diabetes mellitus. New Eng J Med. 1995;333:89-94.

Dyck PJ, Karnes JL, Daube J. Clinical and neuropathological criteria for the diagnosis and staging of the diabetic polyneuropathy. Brain. 1985;108:861-880.

Ishii DN. Implications of insulin-like growth factors in pathogenesis of diabetic neuropathy. Brain Research Reviews. 1995;20:47-67.

Giugliano D, Ciriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-267.

Sima AAF, Brismar T. Reversible diabetic nerve disfunction: structural correlates to electrophysiological abnormalities. Ann Neurol. 1985;18:21-29.

Brismar T, Sima AAF, Grenne DA. Reversible and irreversible nodal disfunction in diabetic neuropathy. Ann Neurol. 1987;21:504-507.

Dumitru D. Generalized peripheral neuropathies. In: Dumitru D. Electrodiagnostic medicine. Philadelphia: Hanley & Belfus; 1995. p. 741-850.

Schmidt RE, Dorsey DA, Beaudet LN. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. J Neuropathol Exp Neurol. 1998;57:1175-1189.

Low PA. Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve. 1987;10:121-128.

Diemel LT, Cai F, Anand P. Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diad Med. 1999;16:113-118.

Elias KA, Cronin MJ, Stewart TA. Peripheral neuropathy in transgenic diabetic mice. Diabetes. 1998;47:1637-1642.

Apfel SC, Kessler JA, Adornato BT. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. 1998;51:695-702.

Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol. 1995;52:1053-1061.

Stewart JD, McKelvey R, Durcan L. Chronic inflamatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Science. 1996;142:59-64.

Low PA. Autonomic neuropathies. Curr Opin Neurol. 1998;11:531-537.

Vinik AI. Diagnosis and management of diabetic neuropathy. Clinics in Geriatric Medicine. 1999;51:293-321.

Andersen H, Stalberg E, Gjerstad MD, Jakobsen J. Association of muscle strength and electrophysiological measures of reinnervation in diabetic neuropathy. Muscle Nerve. 1998;21:1647-1654.

Pfeifer MA, Ross DR, Schrage JP. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care. 1993;16:1103-1115.

Kong MA, Horowitz M, Dipappsci KLJ, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22:503-507.

Ducher M, Cerutti C, Gustin MD. Noninvasive exploration of cardiac autonomic neuropathy. Diabetes Care. 1999;22:388-393.

Ewing DJ, Martyn CN, Yong RJ, Clarce BF. The value of cardiovascular autonomic function tests: 10 years of experience in diabetes. Diabetes Care. 1985;8:494-498.

Jermend J, Davidovits Z, Khoor S. Silent coronary artery disease in diabetic patients with cardiac autonomic neuropathy. Diabetes Care. 1994;17:1231-1232.

Rathman W, Ziegler D, Jahnke M. Mortality in diabetic patients with cardivascular autonomic neuropathy. Diabet Med. 1993;10:820-824.

Watanabe K, Hagura R, Akamura Y. Characteristics of cranial nerve palsies in diabetic patients. Diad Res Clin Pract. 1990;10:19-27.

Urban PP, Forst T, Lenfers M. Incidence of subclinical trigeminal and facial involvement in diabetes mellitus. Electromyogr Clin Neurophysiol. 1999;39:267-272.

Quasthoff S. The role of axonal ion conductances in diabetic neuropathy: a review. Muscle Nerve. 1998;21:1246-1255.

Wilson JR, Stittsworth JD, Kadir A, Fisher MA. Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy. Muscle Nerve. 1998;21:1228-1230.

Kraft GH. Peripheral neuropathies. In: Johnson EW. Practical electromyography. Baltimore: Williams & Wilkins; 1988. p. 246-318.

DeLisa JA, Lee HJ, Baran EM, Lai KS, Spielholz N. Manual of nerve conduction velocity and clinical neurophysiology. 3rd ed. New York: Raven Press; 1994. p. 144-145.

Andersen H, Stalberg E, Falck B. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 1997;20:1296-1302.

Falck B, Stalberg E, Bischoff C. Sensory nerve conduction studies with surface electrodes. Methods Clin Neurophysiol. 1994;5:1-20.

Stalberg E, Falck B. Clinical motor nerve conduction studies. Methods Clin Neurophysiol. 1993;4:61-80.

Toyokura M, Ishida A. Clinical significance of the F-wave area in diabetic polyneuropathy. Electromyogr Clin Neurophysiol. 1999;39:93-99.

Bril V, Ellison R, Ngo M. Electrophysiological monitoring in clinical trials. Muscle Nerve. 1998;21:1368-1373.

Downloads

Published

2000-04-09

Issue

Vol. 7 No. 1 (2000)

Section

Artigo de Revisão e Atualização

License

Copyright (c) 2000 Acta Fisiátrica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Dias RJS, Carneiro AP. Neuropatia diabética: fisiopatologia, clínica e eletroneuromiografia. Acta Fisiátr. [Internet]. 2000 Apr. 9 [cited 2024 Jul. 19];7(1):35-44. Available from: https://periodicos.usp.br/actafisiatrica/article/view/102254